Loading
Coiled Therapeutics plc Stock: price and insider trades · United Kingdom
1 insider bought €47k of shares over the last 90 days, the latest filed 28 Sept 2026.
Coiled Therapeutics plc: what insiders have been doing
Insider filings for Coiled Therapeutics plc are scarce in the RNS (LSE) feed, the latest one published on 28 September 2026. This page will fill in as new trades are disclosed. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€47,280
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleStephen West1 buy
Analyst consensus: bullish or bearish?
Analysts rate Coiled Therapeutics plc Strong Buy (bullish), based on 1 analysts. Average price target: £21.95.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
£0.06
Analyst consensus
1 analystsStrong buy
£21.95Target £21.95(+35738%)£21.95
Income statement
EBITDA-£3.4M
Net income-£3.4M0.0% margin
Valuation
PER (forward)-546.4x
Balance sheet & cash
Market cap£26.1M
Free Cash Flow-£645.6k
Profitability & ownership
% insiders62.4%
% institutions7.2%
Last declaration on 28 September 2026
Declarations1 total
531,743 shares@ £0.0765100.0% of flowLondon Stock Exchange (XLON); AIMISIN GB00BSHRN331FCA-NSM:26fe942e-7432-4ff8-90a0-78c3fc540d9e
Canonical exit: 27 Dec 2026 (T+90)
1 of 1 declaration
About Coiled Therapeutics plc
Coiled Therapeutics plc is a company focused on developing innovative therapies based on advanced technologies. It is listed on the London Stock Exchange.
